» Articles » PMID: 15274557

Doxorubicin-poly(acrylic Acid) Complexes: Interaction with Liposomes

Overview
Journal Langmuir
Specialty Chemistry
Date 2004 Jul 28
PMID 15274557
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Complexation of antitumor drug, doxorubicin (DOX), with poly(acrylic acid) (PAA) in buffer solutions was examined. The DOX-to-PAA binding was governed by electrostatic and stacking interactions resulting in a complex of characteristic composition with a PAA/DOX = 1.6 molar ratio. Sizes of the complex particles were found to lie in 600-900-nm range. However, the particles were able to interact with small neutral egg yolk lecithin liposomes (80-100 nm in diameter), a ternary DOX/PAA/liposome complex being formed. The observations and conclusions we made may be useful for interpreting biological effects of polymer-based bioactive constructs.

Citing Articles

Enzymatically Triggered Drug Release from Microgels Controlled by Glucose Concentration.

Kaniewska K, Mackiewicz M, Smutok O, Gonchar M, Katz E, Karbarz M ACS Biomater Sci Eng. 2024; 10(10):6415-6424.

PMID: 39356930 PMC: 11480938. DOI: 10.1021/acsbiomaterials.4c01721.


Liposome-polymer complex for drug delivery system and vaccine stabilization.

Sriwidodo , Umar A, Wathoni N, Zothantluanga J, Das S, Luckanagul J Heliyon. 2022; 8(2):e08934.

PMID: 35243059 PMC: 8861389. DOI: 10.1016/j.heliyon.2022.e08934.


Amylase-Sensitive Polymeric Nanoparticles Based on Dextran Sulfate and Doxorubicin with Anticoagulant Activity.

Pyataev N, Petrov P, Minaeva O, Zharkov M, Kulikov O, Kokorev A Polymers (Basel). 2019; 11(5).

PMID: 31130638 PMC: 6571953. DOI: 10.3390/polym11050921.


Star-Graft Quarterpolymer-Based Polymersomes as Nanocarriers for Co-Delivery of Hydrophilic/Hydrophobic Chemotherapeutic Agents.

Iatridi Z, Angelopoulou A, Voulgari E, Avgoustakis K, Tsitsilianis C ACS Omega. 2018; 3(9):11896-11908.

PMID: 30320280 PMC: 6173558. DOI: 10.1021/acsomega.8b01437.


Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells.

Beals N, Thiagarajan P, Soehnlen E, Das A, Reizes O, Lathia J ACS Omega. 2018; 2(11):7702-7713.

PMID: 30023561 PMC: 6044869. DOI: 10.1021/acsomega.7b01168.